home / stock / gnpx / gnpx news


GNPX News and Press, Genprex Inc. From 03/19/20

Stock Information

Company Name: Genprex Inc.
Stock Symbol: GNPX
Market: NASDAQ
Website: genprex.com

Menu

GNPX GNPX Quote GNPX Short GNPX News GNPX Articles GNPX Message Board
Get GNPX Alerts

News, Short Squeeze, Breakout and More Instantly...

GNPX - FCAU, HLT among premarket losers

BioNTech SE (NASDAQ: BNTX ) -16% . More news on: BioNTech SE, Mesoblast Limited, InterContinental Hotels Group PLC, Stocks on the move, , Read more ...

GNPX - BA, MT among premarket losers

Sasol (NYSE: SSL ) -36% . More news on: Sasol Limited, Sibanye Stillwater Limited, Caesars Entertainment Corporation, Stocks on the move, , Read more ...

GNPX - Crude crash and coronavirus weigh on Energy and biotech stocks premarket

Quorum Health (NYSE: QHC ) -53% . More news on: Quorum Health Corporation, Sasol Limited, Enable Midstream Partners, LP, Stocks on the move, Read more ...

GNPX - A Basket Of Biotechs

It is an exciting time in biotech. It seems like the big challenges are within reach. Cancer, diabetes, infectious diseases. Not everything, not right away. There are still a lot of bald men, for example. And unfortunately, Alzheimer’s seems intractable. But for investors that can mea...

GNPX - W, VMW among premarket losers

Big Lots (NYSE: BIG )  -35%  on  Q4 earnings . More news on: Big Lots, Inc., Tonix Pharmaceuticals Holding Corp., Celsion Corporation, Stocks on the move, , Read more ...

GNPX - ABEV, PLAN among premarket losers

Anaplan (NYSE: PLAN )  -29%   despite Q4 beat . More news on: Anaplan, Inc., Continental Resources, Inc., Nutanix, Inc., Stocks on the move, , Read more ...

GNPX - Genprex Closes $25.5 million Offerings Successfully

The biotech sector has been one of the better stock market performers for some time now, and the trend continued in 2020 as well so far. One of the biotech stocks that deserve attention at this point is that of Genprex Inc ( NASDAQ: GNPX ) , which has emerged as the biggest biotech stock gai...

GNPX - Genprex, Inc. Announces Closing of $17,500,000 Common Stock Offering At-The-Market and Without Warrants

Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, announced today that it closed its previously announc...

GNPX - NetworkNewsBreaks - Genprex, Inc. (NASDAQ: GNPX) Prices $17,500,000 Common Stock Offering At-The-Market

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, on Wednesday announced that it has entered into securities purchase agreements with institutional investors for the purchase and ...

GNPX - GRPN, SLS, ENPH and SSTI among midday movers

Gainers: Myomo (NYSEMKT: MYO ) +48% . More news on: Myomo, Inc., Enphase Energy, Inc., Altisource Asset Management Corporation, Stocks on the move, , Read more ...

Previous 10 Next 10